Rare
lephants
Screener
Toggle theme
S
China SXT Pharmaceuticals, Inc.
SXTC
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2020
FY2019
FY2018
FY2017
Total Cash from Operations:
$2.0M
Line Item
Value
% of Total
Capital Expenditures
$436.0K
22.3%
Other Investing
$614.7K
31.4%
Other Financing
$314.2K
16.1%
Net Cash Flow
$592.2K
30.3%
Download CSV